Grifols prices $4.8bn of euro and dollar loans at 300bp over
Spanish pharmaceutical company Grifols has cut the traditional euro premium on its new $4.8bn-equivalent refinancing loan package to achieve identical margins on the euro and dollar drawn tranches.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts